Limited knowledge on progestogen-only contraception and risk of venous thromboembolism
Objective. To assess the current knowledge concerning progestogen-only contraception (POC) and risks of venous thromboembolism (VTE). Design and setting. Systematic review of the literature on observational and analytical studies reporting risk estimates for VTE in women exposed to POCs. Methods and...
Gespeichert in:
Veröffentlicht in: | Acta obstetricia et gynecologica Scandinavica 2009-01, Vol.88 (3), p.261-266 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 266 |
---|---|
container_issue | 3 |
container_start_page | 261 |
container_title | Acta obstetricia et gynecologica Scandinavica |
container_volume | 88 |
creator | Bergendal, Annica Odlind, Viveca Persson, Ingemar Kieler, Helle |
description | Objective. To assess the current knowledge concerning progestogen-only contraception (POC) and risks of venous thromboembolism (VTE). Design and setting. Systematic review of the literature on observational and analytical studies reporting risk estimates for VTE in women exposed to POCs. Methods and main outcome measures. We performed a computerized literature search in the Pub Med, Embase, and the Cochrane Library for studies published between 1966 and February 13, 2008. Based on the evaluated studies we calculated an overall risk estimate for VTE in association with POC. Results. Four case-control studies and one cohort study were included. Of the case-control studies, three reported an increased risk and one a decreased risk of VTE. The cohort study found divergent results depending on the type of statistical analysis used. None of the results was statistically significant. The overall odds ratio for POC-associated VTE in the four case-control studies was 1.45 (95% CI=0.92-2.26). Conclusions. The risk of VTE associated with use of POCs is poorly investigated. The slightly elevated overall risk estimate might suggest an association between POC and an increased risk for VTE. The results must, however, be interpreted with caution due to the possibility of residual confounding. Well-designed studies with sufficient statistical power to evaluate risks of VTE with POC are warranted. |
doi_str_mv | 10.1080/00016340902730375 |
format | Article |
fullrecord | <record><control><sourceid>istex_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_560056</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ark_67375_WNG_36FS53DQ_3</sourcerecordid><originalsourceid>FETCH-LOGICAL-c6581-7edb2db32aa1d2613d9063f77024885cac27e22f877b28d28ffc2844a150a9f43</originalsourceid><addsrcrecordid>eNqFkcuO0zAYRi0EYsrAA7BB2bAj4FtiR6yqGaYgVYwQMCwtx5fW08Su7ITSt8dVQ7tAAwvfz7Hl_wPgJYJvEeTwHYQQ1YTCBmJGIGHVIzBDNYQlpAg_BrPDeZmB5gI8S-k-rzCj_Cm4QA1imGI8A3dL17vB6GLjw64zemWK4IttDCuThtz5MvhuX6jghyiV2Q4uH0uvi-jSpgi2-Gl8GFMxrGPo22By61zqn4MnVnbJvJjGS_D95sO3q4_l8nbx6Wq-LFVdcVQyo1usW4KlRBrXiOgG1sQyBjHlvFJSYWYwtpyxFnONubUKc0olqqBsLCWXoDzem3ZmO7ZiG10v414E6cS0tckzI6pclqrOfPMgnz-tz9IfESFOKkQrlt03D7rX7m4uQlyJcRSI5jh4xtERVzGkFI09CQiKQ3zir_iy8-ro5Pt7o8_GlFcGXk-ATEp2NkqvXDpxGGHIED7UpTpyO9eZ_f9fFvPbBW_QuZ4uDebXyZNxI2p24H58XghS33ytyPUXQTL_fuK9DbGXayO7Ya1kNOI-jNHn7P_x3d_mxdR1</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Limited knowledge on progestogen-only contraception and risk of venous thromboembolism</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Bergendal, Annica ; Odlind, Viveca ; Persson, Ingemar ; Kieler, Helle</creator><creatorcontrib>Bergendal, Annica ; Odlind, Viveca ; Persson, Ingemar ; Kieler, Helle</creatorcontrib><description>Objective. To assess the current knowledge concerning progestogen-only contraception (POC) and risks of venous thromboembolism (VTE). Design and setting. Systematic review of the literature on observational and analytical studies reporting risk estimates for VTE in women exposed to POCs. Methods and main outcome measures. We performed a computerized literature search in the Pub Med, Embase, and the Cochrane Library for studies published between 1966 and February 13, 2008. Based on the evaluated studies we calculated an overall risk estimate for VTE in association with POC. Results. Four case-control studies and one cohort study were included. Of the case-control studies, three reported an increased risk and one a decreased risk of VTE. The cohort study found divergent results depending on the type of statistical analysis used. None of the results was statistically significant. The overall odds ratio for POC-associated VTE in the four case-control studies was 1.45 (95% CI=0.92-2.26). Conclusions. The risk of VTE associated with use of POCs is poorly investigated. The slightly elevated overall risk estimate might suggest an association between POC and an increased risk for VTE. The results must, however, be interpreted with caution due to the possibility of residual confounding. Well-designed studies with sufficient statistical power to evaluate risks of VTE with POC are warranted.</description><identifier>ISSN: 0001-6349</identifier><identifier>ISSN: 1600-0412</identifier><identifier>EISSN: 1600-0412</identifier><identifier>DOI: 10.1080/00016340902730375</identifier><identifier>PMID: 19172422</identifier><identifier>CODEN: AOGSAE</identifier><language>eng</language><publisher>Oxford, UK: Informa UK Ltd</publisher><subject>Biological and medical sciences ; Blood and lymphatic vessels ; Cardiology. Vascular system ; Case-Control Studies ; Cohort Studies ; Contraceptives, Oral, Hormonal - adverse effects ; Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous ; epidemiology ; Female ; Gynecology. Andrology. Obstetrics ; Humans ; Medical sciences ; MEDICIN ; Medicin och hälsovetenskap ; MEDICINE ; observational studies ; Odds Ratio ; Progestins - administration & dosage ; Progestins - adverse effects ; Progestogen-only contraception ; Risk Assessment ; systematic review ; venous thromboembolism ; Venous Thromboembolism - chemically induced</subject><ispartof>Acta obstetricia et gynecologica Scandinavica, 2009-01, Vol.88 (3), p.261-266</ispartof><rights>2009 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2009</rights><rights>Acta Obstet Gynecol Scand 2009</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c6581-7edb2db32aa1d2613d9063f77024885cac27e22f877b28d28ffc2844a150a9f43</citedby><cites>FETCH-LOGICAL-c6581-7edb2db32aa1d2613d9063f77024885cac27e22f877b28d28ffc2844a150a9f43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1080%2F00016340902730375$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1080%2F00016340902730375$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,780,784,885,1417,27923,27924,45573,45574</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21207124$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19172422$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-140278$$DView record from Swedish Publication Index$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:118351457$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Bergendal, Annica</creatorcontrib><creatorcontrib>Odlind, Viveca</creatorcontrib><creatorcontrib>Persson, Ingemar</creatorcontrib><creatorcontrib>Kieler, Helle</creatorcontrib><title>Limited knowledge on progestogen-only contraception and risk of venous thromboembolism</title><title>Acta obstetricia et gynecologica Scandinavica</title><addtitle>Acta Obstet Gynecol Scand</addtitle><description>Objective. To assess the current knowledge concerning progestogen-only contraception (POC) and risks of venous thromboembolism (VTE). Design and setting. Systematic review of the literature on observational and analytical studies reporting risk estimates for VTE in women exposed to POCs. Methods and main outcome measures. We performed a computerized literature search in the Pub Med, Embase, and the Cochrane Library for studies published between 1966 and February 13, 2008. Based on the evaluated studies we calculated an overall risk estimate for VTE in association with POC. Results. Four case-control studies and one cohort study were included. Of the case-control studies, three reported an increased risk and one a decreased risk of VTE. The cohort study found divergent results depending on the type of statistical analysis used. None of the results was statistically significant. The overall odds ratio for POC-associated VTE in the four case-control studies was 1.45 (95% CI=0.92-2.26). Conclusions. The risk of VTE associated with use of POCs is poorly investigated. The slightly elevated overall risk estimate might suggest an association between POC and an increased risk for VTE. The results must, however, be interpreted with caution due to the possibility of residual confounding. Well-designed studies with sufficient statistical power to evaluate risks of VTE with POC are warranted.</description><subject>Biological and medical sciences</subject><subject>Blood and lymphatic vessels</subject><subject>Cardiology. Vascular system</subject><subject>Case-Control Studies</subject><subject>Cohort Studies</subject><subject>Contraceptives, Oral, Hormonal - adverse effects</subject><subject>Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous</subject><subject>epidemiology</subject><subject>Female</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>MEDICIN</subject><subject>Medicin och hälsovetenskap</subject><subject>MEDICINE</subject><subject>observational studies</subject><subject>Odds Ratio</subject><subject>Progestins - administration & dosage</subject><subject>Progestins - adverse effects</subject><subject>Progestogen-only contraception</subject><subject>Risk Assessment</subject><subject>systematic review</subject><subject>venous thromboembolism</subject><subject>Venous Thromboembolism - chemically induced</subject><issn>0001-6349</issn><issn>1600-0412</issn><issn>1600-0412</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkcuO0zAYRi0EYsrAA7BB2bAj4FtiR6yqGaYgVYwQMCwtx5fW08Su7ITSt8dVQ7tAAwvfz7Hl_wPgJYJvEeTwHYQQ1YTCBmJGIGHVIzBDNYQlpAg_BrPDeZmB5gI8S-k-rzCj_Cm4QA1imGI8A3dL17vB6GLjw64zemWK4IttDCuThtz5MvhuX6jghyiV2Q4uH0uvi-jSpgi2-Gl8GFMxrGPo22By61zqn4MnVnbJvJjGS_D95sO3q4_l8nbx6Wq-LFVdcVQyo1usW4KlRBrXiOgG1sQyBjHlvFJSYWYwtpyxFnONubUKc0olqqBsLCWXoDzem3ZmO7ZiG10v414E6cS0tckzI6pclqrOfPMgnz-tz9IfESFOKkQrlt03D7rX7m4uQlyJcRSI5jh4xtERVzGkFI09CQiKQ3zir_iy8-ro5Pt7o8_GlFcGXk-ATEp2NkqvXDpxGGHIED7UpTpyO9eZ_f9fFvPbBW_QuZ4uDebXyZNxI2p24H58XghS33ytyPUXQTL_fuK9DbGXayO7Ya1kNOI-jNHn7P_x3d_mxdR1</recordid><startdate>20090101</startdate><enddate>20090101</enddate><creator>Bergendal, Annica</creator><creator>Odlind, Viveca</creator><creator>Persson, Ingemar</creator><creator>Kieler, Helle</creator><general>Informa UK Ltd</general><general>Blackwell Publishing Ltd</general><general>Blackwell</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>DF2</scope></search><sort><creationdate>20090101</creationdate><title>Limited knowledge on progestogen-only contraception and risk of venous thromboembolism</title><author>Bergendal, Annica ; Odlind, Viveca ; Persson, Ingemar ; Kieler, Helle</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c6581-7edb2db32aa1d2613d9063f77024885cac27e22f877b28d28ffc2844a150a9f43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Biological and medical sciences</topic><topic>Blood and lymphatic vessels</topic><topic>Cardiology. Vascular system</topic><topic>Case-Control Studies</topic><topic>Cohort Studies</topic><topic>Contraceptives, Oral, Hormonal - adverse effects</topic><topic>Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous</topic><topic>epidemiology</topic><topic>Female</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>MEDICIN</topic><topic>Medicin och hälsovetenskap</topic><topic>MEDICINE</topic><topic>observational studies</topic><topic>Odds Ratio</topic><topic>Progestins - administration & dosage</topic><topic>Progestins - adverse effects</topic><topic>Progestogen-only contraception</topic><topic>Risk Assessment</topic><topic>systematic review</topic><topic>venous thromboembolism</topic><topic>Venous Thromboembolism - chemically induced</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bergendal, Annica</creatorcontrib><creatorcontrib>Odlind, Viveca</creatorcontrib><creatorcontrib>Persson, Ingemar</creatorcontrib><creatorcontrib>Kieler, Helle</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Uppsala universitet</collection><jtitle>Acta obstetricia et gynecologica Scandinavica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bergendal, Annica</au><au>Odlind, Viveca</au><au>Persson, Ingemar</au><au>Kieler, Helle</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Limited knowledge on progestogen-only contraception and risk of venous thromboembolism</atitle><jtitle>Acta obstetricia et gynecologica Scandinavica</jtitle><addtitle>Acta Obstet Gynecol Scand</addtitle><date>2009-01-01</date><risdate>2009</risdate><volume>88</volume><issue>3</issue><spage>261</spage><epage>266</epage><pages>261-266</pages><issn>0001-6349</issn><issn>1600-0412</issn><eissn>1600-0412</eissn><coden>AOGSAE</coden><abstract>Objective. To assess the current knowledge concerning progestogen-only contraception (POC) and risks of venous thromboembolism (VTE). Design and setting. Systematic review of the literature on observational and analytical studies reporting risk estimates for VTE in women exposed to POCs. Methods and main outcome measures. We performed a computerized literature search in the Pub Med, Embase, and the Cochrane Library for studies published between 1966 and February 13, 2008. Based on the evaluated studies we calculated an overall risk estimate for VTE in association with POC. Results. Four case-control studies and one cohort study were included. Of the case-control studies, three reported an increased risk and one a decreased risk of VTE. The cohort study found divergent results depending on the type of statistical analysis used. None of the results was statistically significant. The overall odds ratio for POC-associated VTE in the four case-control studies was 1.45 (95% CI=0.92-2.26). Conclusions. The risk of VTE associated with use of POCs is poorly investigated. The slightly elevated overall risk estimate might suggest an association between POC and an increased risk for VTE. The results must, however, be interpreted with caution due to the possibility of residual confounding. Well-designed studies with sufficient statistical power to evaluate risks of VTE with POC are warranted.</abstract><cop>Oxford, UK</cop><pub>Informa UK Ltd</pub><pmid>19172422</pmid><doi>10.1080/00016340902730375</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0001-6349 |
ispartof | Acta obstetricia et gynecologica Scandinavica, 2009-01, Vol.88 (3), p.261-266 |
issn | 0001-6349 1600-0412 1600-0412 |
language | eng |
recordid | cdi_swepub_primary_oai_swepub_ki_se_560056 |
source | MEDLINE; Wiley Online Library All Journals |
subjects | Biological and medical sciences Blood and lymphatic vessels Cardiology. Vascular system Case-Control Studies Cohort Studies Contraceptives, Oral, Hormonal - adverse effects Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous epidemiology Female Gynecology. Andrology. Obstetrics Humans Medical sciences MEDICIN Medicin och hälsovetenskap MEDICINE observational studies Odds Ratio Progestins - administration & dosage Progestins - adverse effects Progestogen-only contraception Risk Assessment systematic review venous thromboembolism Venous Thromboembolism - chemically induced |
title | Limited knowledge on progestogen-only contraception and risk of venous thromboembolism |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T13%3A36%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-istex_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Limited%20knowledge%20on%20progestogen-only%20contraception%20and%20risk%20of%20venous%20thromboembolism&rft.jtitle=Acta%20obstetricia%20et%20gynecologica%20Scandinavica&rft.au=Bergendal,%20Annica&rft.date=2009-01-01&rft.volume=88&rft.issue=3&rft.spage=261&rft.epage=266&rft.pages=261-266&rft.issn=0001-6349&rft.eissn=1600-0412&rft.coden=AOGSAE&rft_id=info:doi/10.1080/00016340902730375&rft_dat=%3Cistex_swepu%3Eark_67375_WNG_36FS53DQ_3%3C/istex_swepu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/19172422&rfr_iscdi=true |